tbuckley/cabot-search huggingface dataset:
THE PUBLIC SERVICES
Journal: JAMA (1893)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE COUNCIL ON PHARMACY AND CHEMISTRY: A TWENTY-FIFTH ANNIVERSARY
Journal: JAMA (1930)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Distinguishing depression from functional impairment in the medical outcomes study
Authors: S. F. Jencks
Journal: JAMA (1990)

<h3>In Reply.—</h3> Dr Jencks raises important issues regarding (1) the overlap of symptoms of depression with functional status, (2) comparison of patients with depressive symptoms above a specific threshold with medically ill patients without confirmed current symptoms, and (3) differences in case-finding methods. In response, we first discuss the nature of the conditions studied and then comment on each issue. Depression is a condition that is only defined when some symptoms are present; there is no truly asymptomatic depression. Thus, to study the morbidity associated with depression, one must identify persons who are actively depressed. Chronic medical conditions, however, are thought to be ongoing, nonreversible, pathological processes with varying symptom presentation. For such conditions, it makes sense to examine morbidity at any phase of the illness; a study based on only symptomatic cases of hypertension, for example, would not be particularly representative of patients with hypertension. As we noted in
Editorial: Gifted children.
Journal: BMJ (1975)

should be selective in their choice of food at such times.Countries continually exposed to high temperatures are more aware of the dangers.Another hazard is that of paralytic poisoning associated with molluscan shellfish and due to saxatoxin, a neurotoxin pro- duced by marine dinoflagellates and, in particular, Gonyaulax tamarensis.Outbreaks are rare in Britain.11-'3They occur in north and north-eastern coastal regions, where a combination of the Gulf Stream, tides, and plankton bring occasional blooms of protozoa to our shores.Certain laboratories keep watch over shellfish in these areas by routine screening for neurotoxins."4
Scientists 'build a better mouse' to trap biochemical secrets of radiation-resistant cancer cells
Authors: A. A. Skolnick
Journal: JAMA (1992)

SOME SCIENTISTS appear to believe that if you build a better mouse the world will beat a path to your door. Researchers at a number of centers are scurrying to use the latest genetic engineering techniques to create better mice for the study of human diseases and the development of effective therapies. Scientists at the University of North Carolina at Chapel Hill just announced the creation of a mouse model for cystic fibrosis using advanced gene targeting techniques (<i>Science</i>. 1992;257:1083-1095). Others appear to be at various stages of success in making the mouse more like a human, at least in regard to diseases that plague our species. Soon to be announced will be the development of a transgenic mouse that appears much more resistant to lethal levels of ionizing radiation. Researchers at the Uniformed Services University of the Health Sciences (USUHS), Bethesda, Md, are seeking a patent for a genetically
Massachusetts Medical Society
Authors: John Figgis Jewett
Journal: New England Journal of Medicine (1956)

COMMITTEE ON MATERNAL WELFAREPost-Partum HemorrhageA thirty-three-year-old gravida III, para II, experienced a normal pregnancy, uneventful prenatal course and a normal six-hour labor. Under nitrous oxide, oxygen and ether anesthesia, after manual rotation because of a persistent occiput posterior presentation, an infant weighing 3.5 kg. (7 pounds, 14 ounces) was delivered by low forceps. The placenta was delivered within five minutes, followed by routine oxytocics, but the patient started to bleed excessively almost immediately after completion of the third stage. Ergotrate was repeated in fifteen minutes, and although the fundus remained soft, a tight abdominal binder was applied. Shortly . . .
Clinical Electrocardiography.
Journal: JAMA (1922)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE SECRET NOSTRUM VS. THE ETHICAL PROPRIETARY PREPARATION.
Journal: JAMA (1905)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cardiac Arrhythmias: Their Mechanisms, Diagnosis, and Management
Authors: Harry B. Greenberg
Journal: JAMA (1987)

What is the peculiar rhythm I see on my patient's electrocardiogram? What causes it? Should I worry about it? More to the point, what should I do about it? These questions attract me to books such as<i>Cardiac Arrhythmias</i>. In this second edition of his book, Dr Mandel and his 66 contributors not only tell how they recognize the various arrhythmias but also provide a lot of material on the disordered cellular mechanisms responsible for them. In addition, they take up electrophysiological testing, ablative techniques, new modes of pacemaker therapy, and automatic implantable defibrillators. Nor do they slight the currently available antiarrhythmic drugs. At last, after having read about them for years, we have some new and remarkably effective ones. Dr Mandel and his associates cite the curious discrepancy between oral and intravenous verapamil. A bolus of 5 to 10 mg usually stops a patient's supraventricular tachycardia. Should the need
Risk of cancer in patients with psoriasis on biological therapies: a systematic review
Authors: E. Peleva, L.S. Exton, K. Kelley, C.E. Kleyn, K.J. Mason, C.H. Smith
Journal: British Journal of Dermatology (2018)

Psoriasis is a skin condition that leads to inflammation, resulting in red, scaly skin. Biologic therapies are very powerful treatments for psoriasis, but unfortunately, they have significant effects on the immune system, which may increase the possibility of getting cancers. The authors of this study analysed previous research (until August 2016) that looked at whether patients with psoriasis who received biologic therapies got more cancers compared to other patients. Some studies found that there was an increase in certain types of skin cancers, called non‐melanoma skin cancers (NMSC). There was no increase in any other types of cancers in the studies. However, the authors recognised several weaknesses in the studies, which could have affected the results. More research is needed to know whether there really is an increased risk of skin cancer with biologic treatment. Patients participating in long term studies such as the British Association of Dermatologists Biologic Interventions Register (BADBIR) will help to answer this important question.
Universal Screening for Methicillin-Resistant <emph type="ital">Staphylococcus aureus</emph> by Hospitals
Authors: William R. Jarvis
Journal: JAMA (2008)

To the Editor: The study by Dr Harbarth and colleagues1 and the accompanying editorial by Drs Diekema and Climo2 conclude that selective and incomplete expansion of MRSA screening may not prevent MRSA hospital-acquired infections. There are several issues that we believe require clarification.
Council on Drugs. List no. 98. New names
Journal: JAMA (1971)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
NCCN Roundtable Tackles Disparities in Cancer Care
Authors: Clifford Goodman, Moon Chen
Journal: Journal of the National Comprehensive Cancer Network (2017)

During a roundtable on disparities in cancer care at the recent NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care, panelists from a variety of disciplines brought professional and personal experiences to the discussion of eliminating cancer disparities and reducing differences in incidence and mortality rates among minority populations. The panel agreed that these issues must be addressed through research in prevention, screening, clinical trials, and equal access to quality care.
Suspect endocrine disorder in cases of severe adult acne
Journal: JAMA (1981)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites
Authors: M Morales-Ruiz, W Jimenez, D Perez-Sala, J Ros, A Leivas, S Lamas, F Rivera, V Arroyo
Journal: Hepatology (1996)

Arterial vasodilatation is thought to play a major role in the pathogenesis of systemic hemodynamics and renal disturbances occurring in cirrhotic patients. Recent investigations suggest that an increased vascular nitric oxide (NO) production could be implicated in this abnormality. The current study assessed whether increased expression of inducible and/or endothelial nitric oxide synthase (iNOS and eNOS, respectively) occurs in arterial vessels of cirrhotic rats. The investigation was performed in thoracic and abdominal aortas and mesenteric arteries of 10 control rats and 16 cirrhotic rats with ascites. iNOS and eNOS messenger RNA (mRNA) expression were evaluated by polymerase chain reaction and ribonuclease protection assay, respectively. Endothelial NOS protein expression was assessed by Western blot. No iNOS mRNA was detected in arterial vessels of control rats. In contrast iNOS mRNA was consistently detected in all arteries of cirrhotic rats with ascites, the weakest signal being observed in the thoracic aorta and the strongest in the mesenteric artery. Enhanced eNOS mRNA abundance was found in the aorta of cirrhotic animals as compared with controls. Higher eNOS protein expression was noted in the thoracic aorta of cirrhotic rats. These results indicate the existence of increased eNOS and iNOS expression in arterial vessels of cirrhotic rats, suggesting that transcriptional activation of vascular NOSs and the associated nitric oxide hyperproduction may be of major importance in the pathogenesis of arterial vasodilation in cirrhosis.
Quality of Care-Reply
Authors: Roger Hand
Journal: JAMA (1992)

<h3>In Reply.</h3> —We agree entirely with the points made by Dr Friedell. If reimbursement doesn't cover costs, one has a difficult time maintaining a quality product. We believe the problem is with the system, not the hospitals. We disagree with Drs Katterhagan and Howe. There were 224 medical-surgical hospitals in Illinois in 1988. Our study of 99 hospitals accounted for 85% of all breast cancer patients diagnosed in the state that year. Three large urban hospitals with cancer programs that declined to participate in the study accounted for another 10%. This left roughly 5% of all breast cancer patients (less than 300 cases) spread among the 120 or so hospitals without cancer programs (these numbers are in our "Methods" section). We don't think it's fair or worthwhile to examine an institution based on its treatment of, on average, fewer than three patients. The results they present in their letter are
Yield of routine annual laboratory tests in a skilled nursing home population
Authors: M. R. Levinstein
Journal: JAMA (1987)

The yield of routinely performed annual panels of laboratory tests was examined among patients in the skilled nursing facility section of a large, multilevel, long-term—care institution. Of 9270 tests done as part of 336 annual panels in 121 patients over an eight-year period, 17% of the tests yielded abnormal results, and in 36% of the tests, abnormal results were new. Among the 336 panels, 56 (16.7%) had at least one abnormality that was believed to have resulted in some benefit to 30 (24.7%) of the patients. Many of the abnormalities that led to patient benefit could have been detected by periodic monitoring of chronic conditions and their treatment as opposed to true screening tests, and all such abnormalities could have been identified by a complete blood cell count, electrolyte determinations, renal and thyroid function tests, and a urinalysis. The results suggest that a modest panel of annual laboratory tests could limit the potential costs of screening and not result in the loss of potential benefits to patients in skilled nursing facilities. (<i>JAMA</i>1987;258:1909-1915)
Biologic Activity of Purified Cotton Bract Extracts in Man and Guinea Pig
Authors: Marion G. Buck, E. Neil Schachter, Robert B. Fick, William W. Merrill, J. Allen D. Cooper, James J. Keirns, James Oliver, James H. Wall
Journal: Environmental Health Perspectives (1986)

Purified aqueous extracts of cotton bract induce acute airway constriction in healthy volunteers never before exposed to cotton bract. The response is similar to that of textile workers who inhale cotton dust. Approximately 60% of volunteers respond to bract extract with significant decreases in lung function, and these volunteers show an increased number of lymphocytes present in their lungs. Following inhalation of bract, the percent of polymorphonuclear leukocytes increases. Macrophages obtained by bronchoalveolar lavage from volunteers pre-challenged with bract extract release increased amounts of chemotactic factor and superoxide anion. Efforts to detect release of histamine and leukotrienes in volunteers following challenge with bract show no increase in urinary histamine and no significant release of leukotrienes in lung lavage fluid. Purified extracts exhibit chemotactic activity in vitro. They also contract guinea pig ileal longitudinal muscle in vitro. This preparation contains mast cells but no basophils, and the H-1 blocker, mepyramine blocks the contraction. Purified bract extracts contain no histamine or endotoxin but other contractors of smooth muscle may be present. The purified extract exhibits spectral, fluorescent, and radioimmune assay properties similar to a leukotriene B-like component. Cotton bract appears to have direct as well as cell-mediated activities.
In search of Ondine's Curse
Authors: O. Sugar
Journal: JAMA (1978)

A CHRISTMAS Day article in the<i>Chicago Tribune</i>(Dec 25, 1977, pp 1, 26) describes a 16-month-old-child said to be "the only infant known to have beaten Ondine's Curse... a disorder which robs the body of breath." This curse, said the author, was derived from an old German folk tale: Ondine was said to be a sea nymph whose lover betrayed her. To punish him she cursed him with an inability to breathe. Actually, the aforementioned baby is not the only infant to have survived this disorder, which, as a clinical entity, is now well known to respiratory disease specialists, neurosurgeons, and pediatricians. There are, however, many physicians who are not familiar with the syndrome. In this article, I will discuss not the clinical aspects but the origin of the eponym. <h3>The Legend</h3> The term "Ondine's Curse" was first applied to patients by Severinghaus and Mitchell.<sup>1</sup>In 1962 they
Erratum: Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping
Authors: E S Costa, C E Pedreira, S Barrena, Q Lecrevisse, J Flores, S Quijano, J Almeida, M del Carmen García-Macias, S Bottcher, J J M Van Dongen, A Orfao
Journal: Leukemia (2011)
Hypertrichosis
Authors: Anne P. Forbes
Journal: New England Journal of Medicine (1965)

IT may well be that a discussion of the problem of hirsutism, undertaken at this time, will be regretted in but a few months. Many and excellent laboratories are presently investigating this baffling disorder, and few among them are not following promising leads. Clinicians, however, will recall that they have had the sensation of near-solution ever since 1939 when the first clinically practicable method for measuring urinary steroids became available. They have, nevertheless, made little advance in their diagnostic or therapeutic ability. Only enough is known to justify a serious attempt at diagnosis in every case since, among the many . . .
Author index (vol. 1)
Authors: E Gimsofi, J_ Lindridge, R Williams, J Bircher, See Luder, See Schr6der, See Knuth, N Blanckaert, See Duhamel, F Bonino, N Caporaso, P Dentico, G Marin- Ucci, L Valeri, A Craxi, A Ascione, G Raimondo, F Piccinino, G Rocca
Journal: Journal of Hepatology (1985)
Brain Drain from Developing Countries: How can Brain Drain be Converted into Wisdom Gain?
Authors: Sunita Dodani, Ronald E LaPorte
Journal: Journal of the Royal Society of Medicine (2005)

Brain drain is defined as the migration of health personnel in search of the better standard of living and quality of life, higher salaries, access to advanced technology and more stable political conditions in different places worldwide. This migration of health professionals for better opportunities, both within countries and across international borders, is of growing concern worldwide because of its impact on health systems in developing countries. Why do talented people leave their countries and go abroad? What are the consequences of such migrations especially on the educational sector? What policies can be adopted to stem such movements from developing countries to developed countries? This article seeks to raise questions, identify key issues and provide solutions which would enable immigrant health professionals to share their knowledge, skills and innovative capacities and thereby enhancing the economic development of their countries.